SC 13G/A

AMENDMENT NO. 13 TO THE SCHEDULE 13G

Company: Xenon Pharmaceuticals Inc.
Filed: February 14, 2023
Accession Number: 0000921895-23-000486

View Document ↗ View on SEC.gov ↗